戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 dividuals with emphysema secondary to severe alpha1 antitrypsin deficiency.
2 led trial of A1PI treatment in patients with alpha1 antitrypsin deficiency.
3  which underlies misfolding diseases such as alpha1-antitrypsin deficiency.
4 ding Gaucher disease, cystic fibrosis and ZZ alpha1-antitrypsin deficiency.
5 that underlies emphysema in individuals with alpha1-antitrypsin deficiency.
6 stemic inflammatory diseases associated with alpha1-antitrypsin deficiency.
7 apy for treatment of liver diseases, such as alpha1-antitrypsin deficiency.
8 tions in CF, primary ciliary dyskinesia, and alpha1-antitrypsin deficiency.
9  clinically and cost-effective therapies for alpha1-antitrypsin deficiency.
10 re, early-onset COPD probands without severe alpha1-antitrypsin deficiency.
11  a 34-year-old man with cirrhosis related to alpha1-antitrypsin deficiency.
12 ive pulmonary disease (COPD) associated with alpha1-antitrypsin deficiency (AATD).
13 ng, is believed to cause lung destruction in alpha1-antitrypsin deficiency (AATD).
14                               Organoids from alpha1-antitrypsin deficiency and Alagille syndrome pati
15                    The association between Z alpha1-antitrypsin deficiency and juvenile cirrhosis is
16 studies of gene therapy for cystic fibrosis, alpha1-antitrypsin deficiency and lung cancer.
17 ng of genetic and nongenetic modifiers in ZZ alpha1-antitrypsin deficiency and other disorders of pro
18  the end-stage liver disease associated with alpha1-antitrypsin deficiency and underscore the contrib
19 netic disorders, such as cystic fibrosis and alpha1-antitrypsin deficiency, and for other diseases, i
20 with either alcohol-related liver disease or alpha1-antitrypsin deficiency, and only one of the healt
21 he most frequent mutation that causes severe alpha1-antitrypsin deficiency arises in the SERPINA 1 ge
22                                              alpha1-Antitrypsin deficiency (ATD) is a common genetic
23                     In the classical form of alpha1-antitrypsin deficiency (ATD), aberrant intracellu
24 r injury in patients with the classical form alpha1-antitrypsin deficiency (ATD).
25  Less common causes include hemochromatosis, alpha1-antitrypsin deficiency, autoimmune hepatitis, and
26                                       Severe alpha1-antitrypsin deficiency caused by the Z variant (G
27 blished pulmonary mechanics in patients with alpha1-antitrypsin deficiency, chronic obstructive pulmo
28 ess of augmentation therapy (Aug) for severe alpha1-antitrypsin deficiency, comparing strategies of:
29  sensitive measure of disease progression in alpha1 antitrypsin deficiency emphysema than spirometry
30 ents with CF, primary ciliary dyskinesia, or alpha1-antitrypsin deficiency exhibited 3-fold higher mu
31 abolic conditions studied in further detail (alpha1-antitrypsin deficiency, familial hypercholesterol
32 netic hemochromatosis, Wilson's disease, and alpha1-antitrypsin deficiency grow significantly.
33  inhibitor (A1PI) augmentation treatment for alpha1 antitrypsin deficiency has not been substantiated
34 mphysema progression in patients with severe alpha1 antitrypsin deficiency in a randomised controlled
35                                           In alpha1-antitrypsin deficiency, intrahepatocyte accumulat
36                                              Alpha1-antitrypsin deficiency is a genetic disease that
37                                              Alpha1-antitrypsin deficiency is a genetic disorder that
38                                              alpha1-Antitrypsin deficiency is an inherited condition
39                                              alpha1-Antitrypsin deficiency is one of the most common
40 tients with alcohol-related liver disease or alpha1-antitrypsin-deficiency liver disease, and only on
41  drug-induced acute liver failure (one), and alpha1-antitrypsin deficiency (one).
42 verity and distribution in 119 subjects with alpha1-antitrypsin deficiency (PiZ phenotype) and groupe
43 y centres in 13 countries if they had severe alpha1 antitrypsin deficiency (serum concentration <11 m
44                                       Severe alpha1-antitrypsin deficiency (typically PiZZ homozygosi
45                           The association of alpha1-antitrypsin deficiency with the development of em

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。